{
    "Trade/Device Name(s)": [
        "Dochek\u00ae Fentanyl Urine Test Strip",
        "Dochek\u00ae Fentanyl Urine Test Strip Plus",
        "Dochek\u00ae Fentanyl Urine Test Card",
        "Dochek\u00ae Fentanyl Urine Test Card Plus",
        "Dochek\u00ae Fentanyl Urine Test Cup",
        "Dochek\u00ae Fentanyl Urine Test Cup Plus"
    ],
    "Submitter Information": "Guangzhou Decheng Biotechnology Co., Ltd.",
    "510(k) Number": "K242428",
    "Predicate Device Reference 510(k) Number(s)": [
        "K231698"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL"
    ],
    "Summary Letter Date": "December 20, 2024",
    "Summary Letter Received Date": "December 20, 2024",
    "Submission Date": "2025/2/5",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Fentanyl"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Strip",
        "Card",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Dochek Fentanyl Urine Test system for qualitative detection of fentanyl in urine by lateral flow immunoassay",
    "Indications for Use Summary": "Qualitative detection of fentanyl (FTY) in human urine at 1 ng/mL cutoff using lateral flow immunochromatographic assay; provides preliminary results, requires confirmatory testing with GC/MS or LC/MS, for OTC and professional use",
    "fda_folder": "Toxicology"
}